InfuSystem Holdings, Inc. INFU
At closeNov 3, 2026, 4:00 PM EST
After hours · Nov 3, 4:00 PM ET
- YTD
- +42.70%
- 1 year
- +23.08%
- Market cap
- 258.33M
- Revenue (ttm)
- 132.78M
- Profit margin
- 1.12%
- EPS (ttm)
- 0.41
- Shares out
- 21.26M
- P/E ratio
- 31.22
- Forward P/E
- 28.10
- YTD return
- +42.70%
- 1-year return
- +23.08%
- Volume
- 249.43K
- Avg volume
- 136.80K
- Open
- 13.65
- Previous close
- 13.84
- Day's range
- 12.34 – 13.76
- 52-week range
- 7.29 – 14.64
- Beta
- 1.45
- Analysts
- Strong Buy
- Price target
- 14.13 (+10.4%)
2Y +6.26 (+97.51%)
Key statistics
- Enterprise value
- 210.70M
- PEG ratio
- 0.00
- Price / sales
- 1.31
- Price / book
- 3.12
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Revenue growth
- 10.70%
- Free cash flow
- 3.17M
- Total cash
- 380.00K
- Total debt
- 34.38M
- Return on equity
- 2.77%
- Short % of float
- 0.82%
- 50-day average
- 8.02
- 200-day average
- 7.34
Analyst view
Consensus: strong buy
- Target (low)
- 12.50
- Target (mean)
- 14.13
- Target (high)
- 15.00
- Strong buy0
- Buy4
- Hold0
- Sell0
- Strong sell0
Next earnings
Consensus EPS estimate 0.06.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 7, 2024 | Sep 1, 2024 | 0.08 | 0.08 | 0.00 | 0.00% |
| Aug 8, 2024 | Jun 1, 2024 | 0.00 | 0.03 | — | — |
| May 9, 2024 | Mar 1, 2024 | 0.00 | -0.05 | — | — |
| Mar 14, 2024 | Dec 1, 2023 | 0.00 | 0.00 | — | — |
| Nov 7, 2023 | Sep 1, 2023 | 0.00 | 0.03 | — | — |
| Aug 3, 2023 | Jun 1, 2023 | 0.00 | 0.02 | — | — |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Sep 26, 2024 | B. Riley Securities | init | — | Buy |
| Apr 26, 2021 | Northland Capital Markets | init | — | Outperform |
| Aug 31, 2020 | Craig-Hallum | init | — | Buy |
About InfuSystem Holdings, Inc.
InfuSystem Holdings, Inc., through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. The company operates in two segments, Patient Services and Device Solutions. It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states. The company also sells, rents, and leases new and pre-owned pole-mounted and ambulatory infusion pumps, and other durable medical equipment; sells treatment-related consumables; and provides biomedical recertification, maintenance, and repair services for oncology practices, as well as other healthcare site settings comprising hospitals, home care and home infusion providers, skilled nursing and acute care facilities, pain centers, and others. In addition, it offers local and field-based customer support, as well as operates pump service and repair centers. The company was incorporated in 2005 and is headquartered in Rochester Hills, Michigan.
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Country
- United States
- Website
- infusystem.com
News
InfuSystem Announces Change in Third Quarter 2026 Earnings Release Date 
InfuSystem to Report Third Quarter 2026 Financial Results on November 3, 2026 
InfuSystem Holdings, Inc. (INFU) Discusses Business Overview and Growth Strategy with Focus on Patient-First Approach Transcript 
Guardant Health (NASDAQ:GH) versus InfuSystem (NYSE:INFU) Critical Review 
InfuSystem to Host Investor Webcast on September 24, 2026 
InfuSystem (NYSE:INFU) & Exagen (NASDAQ:XGN) Head to Head Contrast 
BlackRock Inc. Takes Position in InfuSystem Holdings, Inc. $INFU 
B. Riley Securities Reiterates Buy on InfuSystems Holdings, Raises Price Target to $20 
InfuSystem Holdings, Inc. (INFU) Q2 2026 Earnings Call Transcript 
12 Health Care Stocks Moving In Tuesday's Intraday Session
Your note
Sign in to keep a note on INFU — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BOYD RALPH F JR | Director | Purchase | May 22, 2024 | 6,000 |
| CHUPA ADDAM | Chief Technology Officer | Conversion of Exercise of derivative security | Oct 30, 2024 | 63,110 |
| DILORIO RICHARD | Chief Executive Officer | Sale | Nov 26, 2024 | 416,659 |
| EICHENBAUM KENNETH D | Director | Purchase | Sep 22, 2024 | 4,000 |
| FUNKE JEROD | Officer | Conversion of Exercise of derivative security | Oct 8, 2024 | 10,831 |
| GENDRON PAUL ANDREW | Director | Purchase | May 19, 2024 | 65,000 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| AWM Investment Company, Inc. | 8.94% | 1,900,000 | 15.48M | Sep 29, 2024 |
| Blackrock Inc. | 5.95% | 1,264,641 | 10.31M | Sep 29, 2024 |
| Vanguard Group Inc | 5.27% | 1,120,401 | 9.13M | Sep 29, 2024 |
| Punch & Associates Investment Management, Inc. | 4.51% | 959,656 | 7.82M | Sep 29, 2024 |
| Minerva Advisors LLC | 3.98% | 846,851 | 6.90M | Sep 29, 2024 |
| Ranger Investment Management, L.p. | 3.62% | 770,625 | 6.28M | Sep 29, 2024 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 3.04% | 646,726 | 5.27M | Sep 29, 2024 |
| First Eagle Small Opportunity Fund | 2.89% | 615,292 | 5.01M | Jul 30, 2024 |
| Heartland Value Fund | 2.35% | 500,000 | 4.07M | Sep 29, 2024 |
| iShares Russell 2000 ETF | 2.09% | 444,434 | 3.62M | Oct 30, 2024 |
| Vanguard Extended Market Index Fund | 1.39% | 296,295 | 2.41M | Sep 29, 2024 |
| Russell Inv Co-U.S. Small Cap Equity Fund | 1.02% | 217,220 | 1.77M | Jul 30, 2024 |